ABUS 240816 4.00P (ABUS240816P4000) Stock Options, News & Quotes

$Arbutus Biopharma (ABUS.US)$ Reuters· 1 min ago
Arbutus Biopharma Corp: Prioritizing Imdusiran Phase 2B Clinical Development. Also planning 40% reduction in workforce

Trytosaveabit

Aug 1 06:28

T 1 news halt

$Arbutus Biopharma (ABUS.US)$ 🤔

porsh

Jul 10 09:09

$Arbutus Biopharma (ABUS.US)$ break 3.42 then good to go

Trytosaveabit

Jun 6 13:30

$Arbutus Biopharma (ABUS.US)$ $Barinthus Biotherapeutics (BRNS.US)$ Arbutus Biopharma (ABUS) said Thursday data from a phase 2a trial in patients with chronic hepatitis B virus infection showed that treatment with imdusiran followed by Barinthus Biotherapeutics' (BRNS) VTP-300 was generally safe and well-tolerated.
Based on preliminary end-of-treatment data, Arbutus said that the therapy resulted in maintenance of lower hepatitis B surface antigen levels during the post-treatment follow-up period.
...